Agilent Technologies and BaseSolve Informatics Announce Co-Marketing Agreement to Deliver An Integrated NGS Workflow in the United States

The collaboration will provide laboratories in the U.S. with a streamlined NGS workflow solution beginning with quality control of the sample, followed by library preparation and Target Enrichment and ending with data reporting. The integrated offering combines Agilent’s portfolio of trusted genomics instrumentation and reagents with BaseSolve’s innovative software solutions. This workflow has been optimized for both Element and Illumina sequencers in the U.S.

Integrated Technologies for Precision Genomics

The agreement focuses on delivering a tested and supported integrated solution.

Agilent’s Genomics Systems:

Agilent provides a comprehensive suite of tools for sample and library preparation, and quality control, including SureSelect, Avida, Magnis, NGS Bravo/NGS Bravo Workstation, TapeStation, Fragment Analyzer, and Femto Pulse Automated Electrophoresis Systems.

BaseSolve’s Bioinformatic Platform:

BaseSolve offers sophisticated bioinformatic analysis and reporting through its flagship AUGMET^TM platform. AUGMET^TM is an end-to-end analysis and reporting suite designed to support NGS workflows, focusing on accuracy, scalability, and compliance.

This collaboration is particularly aimed at enhancing the Whole Exome Sequencing (WES) and Whole Transcriptome Sequencing (WTS) workflows, providing a pathway for research laboratories to adopt the combined solution efficiently.

"This co-marketing agreement with BaseSolve is a testament to our commitment to accelerating genomics and scientific discovery," said Majken Nielsen, Vice President Clinical Businesses, Clinical Diagnostics Division at Agilent Technologies. "By pairing our robust, high-quality sample prep and automation systems with BaseSolve’s expert bioinformatic analysis, we are removing complexity and enabling our research customers to achieve rapid, reliable, and standardized results in their labs."

"The fully executed co-marketing agreement with Agilent marks an exciting milestone for BaseSolve and our AUGMET^TM platform," said Dr. Anupam J Das. "Customers can now easily access an integrated solution that leverages the quality of Agilent's instrumentation with our advanced analysis and reporting capabilities. We look forward to supporting translational research labs globally, particularly within the United States where this solution is immediately accessible through Agilent's quoting structure."

About Agilent Technologies

Agilent Technologies Inc. (NYSE: A) is a global leader in life sciences, diagnostics, and applied chemical markets, delivering innovative solutions that help customers gain the insights they seek. Agilent's instruments, software, services, solutions, and consumables are used by laboratories worldwide to address the full scope of their scientific needs.

About BaseSolve^TM

BaseSolve Informatics Private Limited is a global provider of cutting-edge bioinformatic analysis and reporting solutions for research laboratories. Its flagship platform, AUGMET^TM, delivers end-to-end support for complex genomics workflows. BaseSolve is committed to scalable, compliant, and accurate data analysis.

Contact

Dr. Anupam J Das, PhD

Cofounder & COO BaseSolve Informatics

info@basesolve.com

https://www.basesolve.com | https://augmet.ai

Melanie Herscovitch, PhD

Market Specialist Manager, AFO

Healthcare Diagnostics

Melanie.herscovitch@agilent.com

https://www.agilent.com/